About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(HRAS)2Jic
transgene insertion 2, Central Institute for Experimental Animals, Japan
MGI:3039548
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Irf1tm1Mak/Irf1tm1Mak
Tg(HRAS)2Jic/?
involves: 129S2/SvPas * BALB/c * C57BL/6 MGI:4819237
cx2
Flt4tm1.1Ichi/Flt4+
Tg(HRAS)2Jic/0
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2 MGI:4821322
cx3
Flt4tm1.1Ichi/Flt4+
Krastm1Mok/Kras+
Tg(HRAS)2Jic/0
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2 MGI:4821326
cx4
Hrastm1Mok/Hrastm1Mok
Krastm1Mok/Kras+
Nrastm1Mok/Nras+
Tg(HRAS)2Jic/0
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2 MGI:4821330
cx5
Hrastm1Mok/Hrastm1Mok
Nrastm1Mok/Nrastm1Mok
Tg(HRAS)2Jic/0
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2 MGI:4821332
cx6
Krastm1Mok/Kras+
Nrastm1Mok/Nrastm1Mok
Tg(HRAS)2Jic/0
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2 MGI:4821336
tg7
Tg(HRAS)2Jic/? involves: BALB/c * C57BL/6 MGI:4819236


Genotype
MGI:4819237
cx1
Allelic
Composition
Irf1tm1Mak/Irf1tm1Mak
Tg(HRAS)2Jic/?
Genetic
Background
involves: 129S2/SvPas * BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Irf1tm1Mak mutation (1 available); any Irf1 mutation (19 available)
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 44% develop tumors as compared to 7% of controls
• angiosarcomas observed most frequently




Genotype
MGI:4821322
cx2
Allelic
Composition
Flt4tm1.1Ichi/Flt4+
Tg(HRAS)2Jic/0
Genetic
Background
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Flt4tm1.1Ichi mutation (0 available); any Flt4 mutation (76 available)
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• no mice exhibit chylous ascites




Genotype
MGI:4821326
cx3
Allelic
Composition
Flt4tm1.1Ichi/Flt4+
Krastm1Mok/Kras+
Tg(HRAS)2Jic/0
Genetic
Background
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Flt4tm1.1Ichi mutation (0 available); any Flt4 mutation (76 available)
Krastm1Mok mutation (6 available); any Kras mutation (76 available)
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• 1 of 13 mice develop chylous ascites unlike wild-type mice

immune system
• a few mice exhibit lymphatic vessel hypoplasia




Genotype
MGI:4821330
cx4
Allelic
Composition
Hrastm1Mok/Hrastm1Mok
Krastm1Mok/Kras+
Nrastm1Mok/Nras+
Tg(HRAS)2Jic/0
Genetic
Background
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Mok mutation (15 available); any Hras mutation (30 available)
Krastm1Mok mutation (6 available); any Kras mutation (76 available)
Nrastm1Mok mutation (7 available); any Nras mutation (44 available)
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• no mice exhibit chylous ascites




Genotype
MGI:4821332
cx5
Allelic
Composition
Hrastm1Mok/Hrastm1Mok
Nrastm1Mok/Nrastm1Mok
Tg(HRAS)2Jic/0
Genetic
Background
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hrastm1Mok mutation (15 available); any Hras mutation (30 available)
Nrastm1Mok mutation (7 available); any Nras mutation (44 available)
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• no mice exhibit chylous ascites




Genotype
MGI:4821336
cx6
Allelic
Composition
Krastm1Mok/Kras+
Nrastm1Mok/Nrastm1Mok
Tg(HRAS)2Jic/0
Genetic
Background
involves: 129S/SvEv * BALB/c * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Krastm1Mok mutation (6 available); any Kras mutation (76 available)
Nrastm1Mok mutation (7 available); any Nras mutation (44 available)
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• no mice exhibit chylous ascites




Genotype
MGI:4819236
tg7
Allelic
Composition
Tg(HRAS)2Jic/?
Genetic
Background
involves: BALB/c * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(HRAS)2Jic mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular

mortality/aging
• 77 week survival rate for males is 53% and for females is 32%

limbs/digits/tail
• skeletal myopathy in femoral muscle
• heart tongue and esophagus muscles are normal

growth/size/body
• body weights up to 36 weeks of age are between 80 and 100% of controls

neoplasm
N
• no tumors or pre-neoplasias among F2 mice within the first 6 months
• point mutations often found in transgene in cells from tumors
• 24/50 F2 mice develop tumors within 18 months
• 6/24 F2 mice that developed tumors developed double tumors
• N-methyl-N-nitrosourea (MNU) induced tumors involve point mutations in transgene while ENU induced tumors do not (J:73016)
• transgene overexpression in tumors induced by MNU, ENU, and urethane (J:73016)
• incidence of chemically induced lung adenomas and hyperplasia is higher than in controls (J:101590)
• chemical induction of papillomas and squamous cell carcinomas of the forestomach are common (J:101590)
• chemically induced hemangiosarcomas of the esophagus and small intestine are common (J:101590)
• one example within 3 months
• 3 skin papillomas in 50 F2 mice
• 2 lymphomas in 50 F2 mice
• 4 harderian gland adenocarcinomas in 50 F2 mice
• 8 lung adenocarcinomas in 50 F2 mice
• founder and 2 of 20 F1 mice develop angiosarcoma within 5 months
• 13 angiosarcomas in 50 F2 mice

respiratory system
• 8 lung adenocarcinomas in 50 F2 mice

muscle
• myopathic changes seen at 10-13 weeks in biceps femoris, gastrocnemius, and triceps brachii
• increased cell density occasionally
• diaphragm and soleus are normal
• skeletal myopathy in femoral muscle
• heart tongue and esophagus muscles are normal
• biceps femoris is most susceptible to myopathic changes
• internal architecture of muscle fibers becomes disorganized
• scattered (J:99371)
• some hyaline degeneration of muscle fibers observed (J:135606)
• some increase in interstitial collagen fibers

homeostasis/metabolism
• N-methyl-N-nitrosourea (MNU) induced tumors involve point mutations in transgene while ENU induced tumors do not (J:73016)
• transgene overexpression in tumors induced by MNU, ENU, and urethane (J:73016)
• incidence of chemically induced lung adenomas and hyperplasia is higher than in controls (J:101590)
• chemical induction of papillomas and squamous cell carcinomas of the forestomach are common (J:101590)
• chemically induced hemangiosarcomas of the esophagus and small intestine are common (J:101590)

integument
• one example within 3 months
• 3 skin papillomas in 50 F2 mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory